Salvini Catherine L A, Darlot Benoit, Davison Jack, Martin Mathew P, Tudhope Susan J, Turberville Shannon, Kawamura Akane, Noble Martin E M, Wedge Stephen R, Crawford James J, Waring Michael J
Cancer Research Horizons Therapeutic Innovation Newcastle Drug Discovery Group, Chemistry, School of Natural and Environmental Sciences, Newcastle University Bedson Building NE1 7RU UK
Chemistry, School of Natural and Environmental Sciences, Newcastle University Bedson Building NE1 7RU UK.
Chem Sci. 2023 Jul 12;14(31):8288-8294. doi: 10.1039/d3sc01171b. eCollection 2023 Aug 9.
Optimisation of the affinity of lead compounds is a critical challenge in the identification of drug candidates and chemical probes and is a process that takes many years. Fragment-based drug discovery has become established as one of the methods of choice for drug discovery starting with small, low affinity compounds. Due to their low affinity, the evolution of fragments to desirable levels of affinity is often a key challenge. The accepted best method for increasing the potency of fragments is by iterative fragment growing, which can be very time consuming and complex. Here, we introduce a paradigm for fragment hit optimisation using poised DNA-encoded chemical libraries (DELs). The synthesis of a poised DEL, a partially constructed library that retains a reactive handle, allows the coupling of any active fragment for a specific target protein, allowing rapid discovery of potent ligands. This is illustrated for bromodomain-containing protein 4 (BRD4), in which a weakly binding fragment was coupled to a 42-member poised DEL Suzuki-Miyaura cross coupling resulting in the identification of an inhibitor with 51 nM affinity in a single step, representing an increase in potency of several orders of magnitude from an original fragment. The potency of the compound was shown to arise from the synergistic combination of substructures, which would have been very difficult to discover by any other method and was rationalised by X-ray crystallography. The compound showed attractive lead-like properties suitable for further optimisation and demonstrated BRD4-dependent cellular pharmacology. This work demonstrates the power of poised DELs to rapidly optimise fragments, representing an attractive generic approach to drug discovery.
先导化合物亲和力的优化是药物候选物和化学探针识别过程中的一项关键挑战,且这一过程需要耗费多年时间。基于片段的药物发现已成为从小的、低亲和力化合物开始进行药物发现的首选方法之一。由于其低亲和力,将片段亲和力提升至理想水平往往是一项关键挑战。公认的提高片段效力的最佳方法是通过迭代片段生长,这可能非常耗时且复杂。在此,我们介绍一种使用平衡态DNA编码化学文库(DELs)进行片段命中优化的范例。平衡态DEL的合成,即一种保留反应性手柄的部分构建文库,允许将任何活性片段与特定靶蛋白偶联,从而快速发现强效配体。以含溴结构域蛋白4(BRD4)为例进行说明,其中一个弱结合片段通过铃木 - 宫浦交叉偶联与一个42成员的平衡态DEL偶联,从而在一步中鉴定出一种亲和力为51 nM的抑制剂,相较于原始片段,其效力提高了几个数量级。该化合物的效力源于亚结构的协同组合,而这通过任何其他方法都很难发现,并通过X射线晶体学得以合理化。该化合物表现出适合进一步优化的吸引人的类先导物特性,并展示了BRD4依赖性细胞药理学。这项工作证明了平衡态DEL在快速优化片段方面的能力,代表了一种有吸引力的通用药物发现方法。